These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 14206917

  • 1. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: UROLOGIC AND GYNECOLOGIC NEOPLASMS.
    HOWE CD, SAMUELS ML.
    Cancer Chemother Rep; 1964 Aug; 40():47-8. PubMed ID: 14206917
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MISCELLANEOUS TUMORS.
    BLOEDOW CE.
    Cancer Chemother Rep; 1964 Aug; 40():39-41. PubMed ID: 14206914
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. TOXICITY AND CLINICAL TRIAL OF AZASERINE AND 6-THIOGUANINE IN ADVANCED SOLID MALIGNANT NEOPLASMS.
    SCHROEDER JM, ANSFIELD FJ, CURRERI AR, LEPAGE GA.
    Br J Cancer; 1964 Sep; 13(3):449-58. PubMed ID: 14219537
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CANCER OF THE BREAST.
    SEARS ME.
    Cancer Chemother Rep; 1964 Aug; 40():43. PubMed ID: 14206915
    [No Abstract] [Full Text] [Related]

  • 10. APLASTIC ANEMIA FOLLOWING EXPOSURE TO BENZENE HEXACHLORIDE (LINDANE).
    LOGE JP.
    JAMA; 1965 Jul 12; 193():110-4. PubMed ID: 14304352
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. THE FEASIBILITY OF USING RANDOMIZATION SCHEMES EARLY IN THE CLINICAL TRIALS OF NEW CHEMOTHERAPEUTIC AGENTS: HYDROXYUREA (NSC-32065).
    CARBONE PP, KRANT MJ, MILLER SP, HALL TC, SHNIDER BI, COLSKY J, HORTON J, HOSLEY H, MILLER JM, FREI E.
    Clin Pharmacol Ther; 1965 Jul 12; 6():17-24. PubMed ID: 14253279
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MITHRAMYCIN IN THE TREATMENT OF DISSEMINATED TESTICULAR NEOPLASMS.
    BROWN JH, KENNEDY BJ.
    N Engl J Med; 1965 Jan 21; 272():111-8. PubMed ID: 14224214
    [No Abstract] [Full Text] [Related]

  • 16. HEMATOLOGIC EFFECT OF AN ETHYLENIMINE COMPOUND.
    KENNEDY BJ.
    Cancer Chemother Rep; 1963 Jul 21; 30():25-6. PubMed ID: 14054226
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [THE HEMATOLOGICAL RISK IN TREATMENT WITH HYPOCLYCEMIC SULFONAMIDES].
    TRAISSAC FJ, BERAUD C, DANGOUMAU J.
    Bull World Health Organ; 1964 Jul 21; 31(1):95-100. PubMed ID: 14230898
    [No Abstract] [Full Text] [Related]

  • 19. PHASE I STUDIES OF PYRAZOLE (NSC-45410).
    FOLEY HT, SHNIDER BI, GOLD GL, UZER Y.
    Cancer Chemother Rep; 1965 Feb 21; 44():45-8. PubMed ID: 14294812
    [No Abstract] [Full Text] [Related]

  • 20. [CLINICAL OBSERVATIONS ON THE TOXICITY AND TOLLERABILITY OF LOCAL CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE FOR UTERINE CERVICAL CARCINOMA].
    DAMBROSIO F, FRANGIPANI G, MONTEFORTE C.
    Ann Ostet Ginecol; 1964 May 21; 86():359-406. PubMed ID: 14199005
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.